Premium consumer brands, once a stable bet even in times of market volatility, are no longer quite so insulated from broader economic pressures. Investors have increasingly begun to separate companies, favoring those with true pricing power and brand momentum over those that have struggled as demand has weakened amid slower discretionary spending, inflation, tariff uncertainty, and other factors.
TXN pulled in $850M in Q2 CHIPS incentives. Intel is ramping 18A high-volume manufacturing in Arizona and Oregon, backed by a US government equity stake and a $5B NVIDIA investment related to AI infrastructure.
So far in the Q2 cycle, several companies, including Micron and Citigroup, have been standouts, whereas preliminary results from IBM have been disappointing.
The Trump administration is pressuring foreign memory chipmakers to expand their U.S.
Data centers receive sharp criticism for their high water usage, but the impact on the broader water industry and for investors is also about infrastructure bottlenecks, regulation, and emerging technologies, among other things. Utilities companies must navigate significant changes when hyperscalers enter their territory—in some cases, a new data center operator may immediately become one of the largest customers in the region.
SCHD has returned just under 2% in the past month, outperforming the S&P 500 ETF SPY by almost 100 bps. Year-to-date, almost 30 SCHD holdings have a return that's more than double that of SPY which has returned 9.8% YTD. 31 SCHD holdings look to be trading for an attractive valuation, in that they are at least 10% undervalued but also have a potential future return of above 10%.
When a late-stage clinical trial misses a primary endpoint, the market reaction rarely distributes evenly across the board. The fallout often reveals undeniable fundamental truths about single-asset exposure, pipeline diversification, and the competitive moats protecting established treatments.
The State Street Utilities Select Sector SPDR ETF (XLU) has long been viewed as a defensive investment, preferred by investors seeking stable cash flows, consistent dividends, and lower volatility.
iShares U.S. Insurance ETF (IAK) earns a Very Attractive rating for its superior allocation to profitable, undervalued insurance stocks. IAK's holdings deliver an 18% ROIC, 4% FCF yield, and a low 0.8 PEBV ratio, outperforming SPY and XLF on key profitability and valuation metrics. IAK benefits from strong, recurring macro demand drivers in the insurance industry, including regulatory requirements and embedded coverage in U.S. commerce.
Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS | CVS Price Prediction) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite.
These ETF gainers of June may keep climbing in July as dovish Fed hopes, strong earnings and easing geopolitical risks support markets.
The Federal Communications Commission's first spectrum auction after a four-year hiatus. brought in upwards of $3.5 billion in total, the agency said.